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ABSTRACT
The human papillomavirus (HPV) vaccine uptake in West Virginia is lagging despite
being highly protective against HPV-related diseases. This study aimed to determine
parent and provider perceptions on using pharmacies for HPV vaccination in
adolescents. The study surveyed both parents and providers in a rural academic
institution. Providers were surveyed before and six months after an educational
intervention that instructed providers on local legislation and the logistics of
prescribing the HPV vaccine through pharmacies. The provider survey assessed
awareness of pharmacy vaccine access and prescribing practices. Parents of adolescents
were surveyed to determine what patients might benefit most from pharmacy access
for vaccination. A total of 71 providers completed the initial survey, and 45 completed
the six-month assessment. Only 22.5% were aware of the pharmacy legislation at the
initial survey, and 64.4% were aware at six months (p= <.001). Most providers (69%
on initial survey and 78% at six months) reported that they thought pharmacy access
for vaccination would benefit rural patients. Most providers also reported they would
be “likely” or “very likely” to prescribe the HPV vaccine through a pharmacy. A total of
121 parents completed the survey. Only 16 parents (13.2%) were aware of pharmacy
vaccine access. Of parents whose adolescents had started the series, 78.1% felt
pharmacy vaccine access would have been “very beneficial.” Pharmacy provision of HPV
vaccination for adolescents is underutilized. Parents and providers have favorable views
on using pharmacies for HPV vaccination.
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INTRODUCTION
Human papillomavirus (HPV) infection is responsible
for nearly all cervical cancers, genital warts, and other
cancers of the anogenital region and oropharynx.1-4
In 2018, the estimated number of new diseaseassociated HPV infections in the 15-to 24-years-old
American population was 7.1 million.5 Vaccination
against HPV has been recommended by the Centers
for Disease Control (CDC) since 2006 for females and
2011 for males to prevent new HPV infections and
HPV-associated diseases; however, vaccination rates
remain suboptimal.6 In 2017, in West Virginia, 67.5%
of females and 54% of males had received one dose
of the HPV vaccine series, and only 48.6% of females
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and 39.3% of males had completed the series.6 These
numbers fall well below the Healthy People 2030
target of 80% coverage.
Traveling to a health care provider’s office can be
a barrier to completing the HPV vaccine series,
especially in rural areas. Provision of easier and closer
access for vaccination may improve vaccination
rates,7 which is especially important given that West
Virginia has significantly higher rates of HPV-related
diseases relative to other states. In 2017, legislation
was passed that allows pharmacies to provide HPV
vaccines to patients ages 11-18 with a prescription
from a health care provider (WV House Bill 2518).
Pharmacies are typically more accessible to patients
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than their primary care provider’s offices in rural
areas. Pharmacist administration of other vaccines
has been found to significantly improve access to
immunization.8 The purpose of this study was to
determine parent and provider perceptions of the
feasibility of pharmacy utilization for HPV vaccination
of adolescents.
METHODS
Provider Survey
This study was conducted in a small academic
institution in Appalachia that serves surrounding
rural WV counties. Pediatric, family practice, and
OBGYN providers within this academic institution
were surveyed regarding HPV vaccination practice.
Survey questions included how often they provided
HPV vaccinations, if they were aware of legislation
allowing pharmacy access, Likert scale questions on
the benefits of pharmacy access for HPV vaccination,
and the likelihood of prescribing the HPV vaccine
through a pharmacy in the future. Educational
sessions with providers were then conducted, and
legislation was reviewed along with the logistics of
prescribing the vaccine through a pharmacy in the
electronic health record. Six months later, the same
departments completed the same survey regarding
vaccination practice, awareness of pharmacy
legislation, perspectives about what patient groups
might benefit most from this practice, and the
likelihood of prescribing the vaccine through a
pharmacy in the future.
Parent Survey
Parents of adolescents ages 11-18 were also
surveyed. Parents were recruited from provider
offices within the same academic institution.
Adolescent HPV vaccination status, gender, and
WV county of residence were collected, along
with a survey of Likert scale questions about the
usefulness of pharmacy access for vaccination.
Parent responses were compared by rural and urban
county designation based on the West Virginia
Higher Education Policy Commission definition
based on geographic Health Professional Shortage
Areas (HPSAs), medically underserved areas, and
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census tracks.9 Distance in miles to their pharmacy
and their primary care provider was also recorded.
Parents were asked to consider the pharmacy they
use routinely as their “home” pharmacy to determine
the distance in miles. Parents participating in the
survey were given a water bottle and pen for their
participation.
Provider responses were compared before and six
months after the educational intervention. Parental
responses were compared by adolescent gender and
rural/urban county designation, based on US Census
population codes. Proportions were compared using
Chi-square statistics. Institutional review board
approval was obtained. Funding was obtained
through the Mountains of Hope West Virginia Cancer
Coalition.
RESULTS
P rovider Survey
Seventy-one total participants completed the
initial provider survey. Of these providers, 100%
recommended the HPV vaccine series to their
patients. However, six of the providers reported
not giving the vaccine in practice. Forty-five total
providers completed the follow-up survey. Only two
of these providers reported not giving the vaccine
in practice, and both reported the reason as they
do not see patients in the recommended age group
for the vaccine. Table 1 shows how many providers
completed the surveys from each department
(OBGYN, family practice, and pediatrics). Only 22.5%
of providers (16/71) were aware of the pharmacy
legislation at the initial survey. On the six-month
follow-up survey, 64.4% (29/45) were aware of the
legislation (p<.001). Only one provider reported
providing the HPV vaccine through a pharmacy
at the time of the initial survey, and this was a
pediatrician.
Most providers (49/71, 69% on the initial survey and
35/45, 78% on the follow-up survey) reported that
pharmacy access would benefit rural patients. Most
providers also reported they would be “likely” or
“very likely” to prescribe the vaccine to adolescents
through a pharmacy. This did not change
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TABLE 1: Number of provider participants by department at the initial survey and six-month survey.
significantly at six months (51/71, 71.8% vs. 33/45,
73.3%, p=0.86). However, after six months, only
two providers reported prescribing the vaccine to
an adolescent through a pharmacy. Both providers
were OBGYNs.
Parent Survey
One hundred twenty-one parents completed
the parent survey, representing 196 adolescents
ages 11-18. 94 (47.9%) adolescents had already
completed the HPV vaccine series, 52 (26.5%) had
started the series, and 50 (25.5%) had not yet started
the series. The 50 adolescents who had not yet
started the vaccine series were represented by 45
parents who answered why they had not yet started
the vaccine. Of these, 13/45 (28.8%) reported “safety
concerns,” 3/45 (6.6%) reported they thought it
was “not needed,” 4/45 (8.9%) reported it was “not

recommended by the provider,”1/45 (2.2%) reported
they “did not know about vaccine,” and 23/45 (51%)
reported they “had no recent visits or opportunities.”
One parent did not respond to this question.
Figure 1 shows the percentage of adolescents who
had not started, started, or completed the HPV
vaccine based on living in a rural/urban county and
gender. HPV vaccine completion was not affected
by rural/urban county designation. There was no
difference in adolescents who had not started,
started, or completed the vaccine series when
comparing urban vs. rural. There was a statistical
difference between males not started and males
completed compared to females of these same
criteria. Males were less likely than females to have
completed the vaccine series. Parents who live in
rural counties reported that they lived closer to a
pharmacy than their primary care provider’s office.

FIGURE 1: Percentage of adolescents who had not started, started, or completed the
HPV vaccine based on rural/urban county and gender.
*denotes statistical significance

MARSHALL JOURNAL OF

MEDICINE
™

Expanding Knowledge to Improve Rural Health.

mds.marshall.edu/mjm
© 2022 Marshall Journal of Medicine

Marshall Journal of Medicine
Volume 8 Issue 2

Figure 2 shows the distance in miles that parents
reported they live from a pharmacy and from their
primary care provider.
Only 16/121 (13.2%) parents were aware of
pharmacy access for the HPV vaccine. The majority
(78.1%) of parents whose adolescents had started or
completed the vaccine series felt pharmacy access
would have been “very beneficial.” This did not vary
by rural/urban designation. More parents who live
in rural counties (33.9% vs. 20.7% in urban counties,
p=0.08) had received vaccines for themselves in
pharmacies. However, overall only eight (6.6%)
reported their adolescent had ever received any
vaccine through a pharmacy.

FIGURE 2: Percentage of parents reporting distances
to primary care provider (where they typically
receive vaccines) and pharmacies in miles.
DISCUSSION
Pharmacy provision of the HPV vaccination is
underutilized for adolescents. The first set of
challenges could be related to limited provider
awareness to utilize local pharmacies to administer
the vaccine to aid in series completion. The
majority of surveyed providers agreed that inpharmacy vaccination of adolescent patients
would be beneficial. The provider awareness of the
policy increased threefold following educational
intervention. However, the number of providers
utilizing pharmacists as immunizers remained
low. Studies detail multiple engagement barriers
providers grapple with when prescribing the HPV
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vaccine, including low parent demand, concerns
about vaccine safety, parental understanding
of vaccine benefits, and the management of
reminder or recall notices to complete the series.10,11
Continued physician education is needed to address
these barriers.
The surveyed parents reported a positive outlook on
utilizing pharmacy access for vaccine administration
in rural areas; almost all of this population lived
closer to a community pharmacy than to a primary
care provider. Therefore, pharmacy intervention may
improve series completion as this location may be
more readily accessible to parents. Prior studies have
demonstrated a significantly lower vaccination rate
in rural areas;11,12 however,
differences in vaccination
rates between locations
were not statistically
significant in this study.
This is most likely related
to the patient population
surveyed and the small
sample size. Males were
less likely to receive
or complete the HPV
vaccine than females,
which is consistent with
an established national
trend.6 Continued
community outreach and patient counseling
have been shown to increase parent and patient
awareness and will likely increase the utilization of
pharmacy provision in rural areas.
Study limitations included a limited timeline due
to grant requirements and COVID-19 restrictions,
which limited survey collection. The majority of
the patients surveyed were established with a
primary care provider and had medical insurance
coverage. The uninsured population and adolescent
population not getting regular primary care were
underrepresented. The literature emphasizes the
positive impact a strong recommendation from a
health care provider can have on a parent’s decision
to get their child vaccinated.13 Thus, providers still
have an important role in counseling patients
and their parents prior to the vaccine and should
create connections with pharmacists throughout
the state administering the vaccine to aid in series
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completion. Follow-up research of a providerpharmacist cohort and barriers to provider use
of pharmacies would determine if improved
relationships would increase vaccination rates in
West Virginia.
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